Exploring white matter microstructural alterations in mild cognitive impairment: a multimodal diffusion MRI

Megan R Nelson1,2, Elizabeth G Keeling1,2, Ashley M Stokes1

  • 1Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States.

PubMed
Abstract

Insights

Advanced diffusion MRI reveals early white matter changes in Mild Cognitive Impairment (MCI). Increased free water and altered kurtosis suggest neuroinflammation and microstructural disruption, potentially serving as early biomarkers for cognitive decline.

Area of Science:

  • Neuroimaging
  • Neuroscience
  • Biomarkers

Background:

  • Mild Cognitive Impairment (MCI) represents a preclinical stage between normal aging and dementia.
  • Characterized by subtle cognitive changes, MCI precedes significant daily life impairment.
  • Diffusion MRI (dMRI) is vital for detecting early white matter integrity loss in MCI.

Purpose of the Study:

  • To investigate white matter microstructure differences between MCI and cognitively normal (CN) individuals.
  • To apply advanced dMRI techniques for enhanced sensitivity in detecting microstructural changes.
  • To identify potential imaging biomarkers for early MCI detection.

Main Methods:

  • Utilized the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.
  • Compared white matter microstructure in 46 MCI subjects and 55 CN subjects.
  • Employed advanced dMRI techniques: diffusion kurtosis imaging (DKI), mean signal diffusion kurtosis imaging (MSDKI), and free water imaging (FWI).

Main Results:

  • Found significant differences in white matter integrity between MCI and CN groups.
  • Observed elevated free water levels and altered kurtosis values in MCI subjects.
  • Correlated lower Mini-Mental State Examination (MMSE) scores with higher brain free water levels in the MCI group.

Conclusions:

  • Multimodal advanced diffusion imaging effectively detects early microstructural changes in MCI.
  • Findings suggest neuroinflammation and microstructural integrity disruption in MCI.
  • Advanced dMRI metrics show promise as early biomarkers for cognitive impairment.